Safety profile of rofecoxib as used in general practice in England: results of a prescription-event monitoring study

AIMS: A postmarketing Prescription-Event Monitoring study was undertaken to monitor the safety of rofecoxib, a cyclo-oxygenase (COX)-2 selective inhibitor prescribed in primary care in England. METHODS: Questionnaires requesting clinical event data were sent to prescribing physicians between Februar...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Layton, Deborah, Riley, Jane, Wilton, Lynda V, Shakir, Saad A W
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Science Inc 2003
Assuntos:
Pharmacovigilance
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1894735/
https://ncbi.nlm.nih.gov/pubmed/12580988
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1046/j.1365-2125.2003.01763.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados